Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation
There was no evidence to suggest an interaction between DOACs and statins and the risk of MB. Regular use of DOACs is important to minimize their impact on MB onset.
Authors
- Airam de Burgos‐Gonzalez (ORCID: https://orcid.org/0000-0002-4928-0491)
- Consuelo Huerta-Álvarez
Institutions
- Universidad Complutense de Madrid (ES)
- Agencia Española de Medicamentos y Productos Sanitarios (ES)
- Pharmaceuticals and Medical Devices Agency (JP)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1002/pds.70245
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agencia Española de Medicamentos y Productos Sanitarios